Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Regional hyperthermia in high-risk soft tissue sarcomas
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
The essential role of the in situ immune reaction in human colorectal cancer
Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
[Immunotherapy for glioma]
Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells
Immunotherapy of pancreatic carcinoma
Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells
Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine
Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy